Collierville, TN, United States of America

David Hong

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: The University of Tennessee Research Foundation. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Hong. Retrieved from https://idiyas.com/inventor/david-hong-uzwxj2vi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of David Hong

Introduction

David Hong is an accomplished inventor based in Collierville, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective androgen receptor modulators. His work has the potential to impact various therapeutic areas.

Latest Patents

David Hong holds a patent for "Solid forms of selective androgen receptor modulators." This invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and the process for producing the same. This patent showcases his innovative approach to drug formulation.

Career Highlights

Throughout his career, David has worked with notable organizations such as the University of Tennessee Research Foundation and GTx Corporation. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

David has collaborated with esteemed colleagues, including James T. Dalton and David A. Dickason. These partnerships have enriched his work and fostered a collaborative environment for innovation.

Conclusion

David Hong's contributions to the field of pharmaceuticals through his patent and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…